StonvexLoading…
StonvexStonvexStonvexCore line items from ZUMZ's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-31 | Q4 2025 2025-11-01 | Q3 2025 2025-08-02 | Q2 2025 2025-05-03 |
|---|---|---|---|---|
Revenue | $929.06M | $637.75M | $398.62M | $184.34M |
Operating Income | $17.04M | $-7.99M | $-19.77M | $-19.87M |
Net Income | $13.38M | $-6.17M | $-15.33M | $-14.33M |
EPS (Diluted) | $0.78 | $-0.36 | $-0.88 | $-0.79 |
Total Assets | $644.17M | $633.11M | $623.39M | $599.10M |
Total Liabilities | $319.89M | $334.57M | $330.95M | $300.62M |
Cash & Equivalents | $127.86M | $80.14M | $78.80M | $62.52M |
Free Cash Flow OCF − CapEx | $42.41M | $-11.73M | $-14.82M | $-24.30M |
Shares Outstanding | 16.97M | 16.95M | 17.22M | 17.77M |